|
Formulations to Inhibit Hemotoxic Venoms
This invention uses the chemical element of Ruthenium compounded with other chemical substances and in conjunction with a carbon monoxide releasing molecule (CORM-2) as an anti-venom against four different venoms from the genera Bothrops, Calloselasma, Echis, and Oxyuranus.
Background:
According to the World Health Organization, it is estimated that...
Published: 4/3/2023
|
Inventor(s): Vance Nielsen
Keywords(s):
Category(s): Technology Classifications > Healthcare Portfolios > Emergency Medicine, Technology Classifications > Life Sciences > Drug Delivery, Technology Classifications > Life Sciences > Therapeutics, Technology Classifications > Medical Devices
|
|
New Therapy to Prevent Venom Induced Coagulopathy
This invention is the use of iron and carbon monoxide to increase clot formation after venomous snake bite. Venom exposure impairs the blood’s ability to clot. Serious complications may result in life threatening hemorrhage. This new therapy can be used as a bridging therapy between when the snake bite occurs and when the anti-venom can be given...
Published: 4/3/2023
|
Inventor(s): Vance Nielsen, Leslie Boyer
Keywords(s):
Category(s): Technology Classifications > Life Sciences > Therapeutics
|
|
Method for Detecting Iron-Specific Hypercoagulation
This technology is a novel method for detecting clotting parameters related to iron-specific hypercoagulation in settings such as sickle cell disease, hemodialysis, mechanical circulatory support and repeated blood transfusions.
Background:
Iron-mediated hypercoagulation is the result of increased plasma concentrations of iron. Utilizing information...
Published: 5/15/2024
|
Inventor(s): Vance Nielsen
Keywords(s):
Category(s): Technology Classifications > Life Sciences > Diagnostics
|
